Loading...

CELC CELCUITY INC Investments/Divestments 8-K Filing

CLCT

CLC

CELCUITY INC

(CELC)

2023 8-K

Show Summary

Summary

Contract Renewal

Financial Statements

Financial Results

Q3 Financial Results

Q2 Financial Results

Underwriting Agreement

Loan Agreement for Phase 3 ...

Earnings Report

Annual Meeting and Plan Ame...

Loan Agreement Amendment

Earnings Release

Investment Disposal

Earnings Reports

Private Placement

Compensation Program Update

Clinical Trial and Collabor...

Financial Results for Q2 2023

Financial Results

Annual Meeting Approval

Earnings Report

Lease Amendment

Deposit Account with Silico...

External Links:

Celcuity Inc. announced the initiation of a Phase 1b/2 clinical trial for metastatic castration resistant prostate cancer (mCRPC) and a clinical trial collaboration and supply agreement.

AI Assistant

CELCUITY INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.